SHINE SA will now temporarily provide a full 28-day supply of Post-exposure Prophylaxis (PEP) medication in place of the usual five-day starter pack. This measure has been put in place with the assistance of SA Health to help limit movement during the COVID-19 pandemic.
Prior to the pandemic, clients received a five-day HIV PEP starter pack and then the remaining medication after a follow-up appointment. Clients can now call SHINE SA for a telehealth appointment where our team will guide clients through the process including supply of the medications and blood tests. Follow-up care arrangements will remain in place.
What is PEP?
PEP is a four week long course of medication taken to reduce the risk of HIV infection. It needs to be initiated within 72 hours of possible contact with HIV in order to help prevent the chance of infection. Exposure can occur through unprotected sex or the sharing of needles and other injection equipment.
It’s important that PEP is accessed as soon as possible after you think you may been exposed to HIV. If you are outside of the time-frame you can still contact your local GP or SHINE SA for further assistance.
What are the most common reasons for needing PEP?
Sex without a condom or sex where a condom broke or slipped off, with a person who has, or might have, HIV.
Sharing needles or syringes with a person who has, or might have, HIV.
How can I find out more?
The PEP Hotline is available 24 hours a day on 1800 022 026. The Registered Nurse on the PEP hotline will help assess your needs and indicate where to access PEP near you.
To speak to SHINE SA about accessing PEP call 8300 5300.
To learn more about PEP you can visit the SAMESH website or call 7099 5300.
Australian Federation of AIDS Organisations (AFAO), March 30th 2020
From 1 April 2020 Truvada for HIV treatment and for pre-exposure prophylaxis (PrEP) will no longer be available through the Pharmaceutical Benefits Scheme (PBS).
There are alternatives to Truvada for PrEP in Australia.
Community members eligible for PrEP can access generic versions of Truvada supplied by Apotex, Mylan and Lupin Generic Health. The drugs manufactured by these three suppliers contain the same active ingredients as Truvada.
In addition, from October 2020 Atripla will be delisted. A generic equivalent of Atripla has been approved by the PBS for community members who wish to continue using Atripla.
We encourage you to talk to your prescribing doctor if you want more information about these changes.
For more information, visit the following websites:
The number of gay and bisexual men using PrEP to prevent HIV infection has almost doubled in the last two years, according to the latest report from the PrEPARE Project.
The national online survey of Australian gay and bisexual men found that 43% of gay and bisexual men had used the antiretroviral drug in 2019, up from 24% in 2017. This increase aligns with falling HIV infections among gay and bisexual men in many jurisdictions.
The PrEP users surveyed reported positive experiences of using the drug, with the majority reporting reduced concern about HIV and increased sexual pleasure as a result. They also reported fewer concerns about disclosing PrEP use to others.
Read the 2019 survey report by the Centre for Social Research in Health.
For people living with HIV, sexual adjustment after diagnosis is affected by fears of transmitting the virus and of possible rejection by sexual partners, new qualitative research shows. Healthy sexual adjustment over time is facilitated by partner acceptance; peer, community and professional support; and up-to-date knowledge of HIV transmission, including U=U.
Barriers to healthy sexual adjustment include the persistence of undue fears of transmission and rejection long after diagnosis, which may result in avoiding sex or pairing it with drugs and alcohol. Based on these findings, Dr Ben Huntingdon and colleagues at the University of Sydney propose a new model of sexual adjustment to HIV, published in the BMC Infectious Diseases journal.
Thirty participants (19 male, 11 female) out of 45 PLWH who agreed to be contacted completed the interview and questionnaire as part of the study.
U and me Can Stop HIV: this 8-minute animated video is designed to reach Aboriginal and Torres Strait Islander people with the latest information on HIV.
Animations can help explain the facts about STIs and BBVs in an engaging way that’s easy to understand, and not too confronting. YoungDeadlyFree have produced these animations for young people to access directly via social media but they’re also great tools for community education.
As well as setting out the facts about STIs and BBVs, each of these animations aims to normalise STI and BBV testing, and address the stigma and shame we can feel when talking about sex, STIs and BBVs.